Compare Guardant Health Inc. Common Stock (GH) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Guardant Health Inc. Common Stock vs ImmunityBio Inc. Common Stock — how do they compare? Guardant Health Inc. Common Stock trades at $167.29 (market cap $22.22B), while ImmunityBio Inc. Common Stock trades at $10.53 (market cap $10.51B). The key difference: Guardant Health Inc. Common Stock is far larger — about 2.1× ImmunityBio Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is more actively traded (10,445,785 versus 1,589,453). Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 1 Days and ImmunityBio Inc. Common Stock for 1 Days on average.
| GH | IBRX | |
|---|---|---|
Market Cap | $22.22B | $10.51B |
Volume | 1,589,453 | 10,445,785 |
Sector | Health | Health |
52-Week High | $187.22 | $11.55 |
52-Week Low | $61.73 | $1.98 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $22.86B | $10.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Guardant Health Inc. Common Stock
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →
